Viewing Study NCT04034251

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-07-06 @ 2:11 AM
Study NCT ID: NCT04034251
Status: COMPLETED
Last Update Posted: 2025-02-03
First Post: 2019-07-25
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Adenocarcinoma View
None Gastric Cancer View
None Esophagogastric Junction View
None Peritoneal Carcinomatosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gastroesophageal Junction (Siewert III) Adenocarcinoma View
None Intravenous Chemotherapy View
None Progression Free Survival View
None Peritoneal Metastasis View
None Intraperitoneal Chemotherapy View